CONCLUSIONS: Increase in serum copeptin levels from stage 1 to stage 5 of CKD suggest its predictive role in T2DM associated nephropathy, supporting its potential role as an early biomarker. This evidence concerns the gene AVP and type 2 diabetes mellitus.